6:02 PM
 | 
Oct 31, 2013
 |  BC Extra  |  Financial News

AstraZeneca misses Street, discloses government investigations

AstraZeneca plc (LSE:AZN; NYSE:AZN) announced 3Q13 earnings on Thursday that missed the Street and disclosed two government investigations. The pharma also named Marc Dunoyer as CFO, replacing Simon Lowth, who departed. Dunoyer joined AstraZeneca in June as EVP of global portfolio and strategy. He is the former global head of rare diseases at GlaxoSmithKline plc (LSE:GSK;...

Read the full 267 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >